Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
Recruiting now · Phase 2
Conditions studied: Triple Negative Breast Neoplasms
In brief
The goal of this clinical trial is to evaluate the efficacity and safety of pembrolizumab and capecitabine on the invasive disease-free survival, in participants who have triple negative breast cancer (TNBC) with residual disease after neoadjuvant chemotherapy associated with pembrolizumab.
Key facts
- Study ID
- NCT05973864
- Run by
- UNICANCER
- People needed
- 220
- Starts
- 2025-03-11
- Expected to finish
- 2028-08-01
- Last updated by the study team
- 2025-11-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- CHU Amiens Picardie_Site Sud — Amiens, France (enrolling)
- Institut Sainte Catherine — Avignon, France (enrolling)
- Centre Hospitalier de la Côte Basque — Bayonne, France (enrolling)
- CHU Jean Minoz — Besançon, France (enrolling)
- Polyclinique Bordeaux Nord Aquitaine — Bordeaux, France (enrolling)
- Centre François Baclesse — Caen, France (enrolling)
- Centre Georges-François Leclerc — Dijon, France (enrolling)
- CHD Vendee — La Roche-sur-Yon, France (enrolling)
- Centre Oscar Lambret — Lille, France (enrolling)
- Centre Léon Bérard — Lyon, France (enrolling)
- Institut Paoli-Calmettes — Marseille, France (enrolling)
- Institut Curie — Paris, France (enrolling)
- Clinique de La Croix du sud — Quint-Fonsegrives, France (enrolling)
- Institut Godinot — Reims, France (enrolling)
- Institut Curie — Saint-Cloud, France (enrolling)
- Clinique Mutualiste de l'Estuaire — Saint-Nazaire, France (enrolling)
- Centre Paul Strauss — Strasbourg, France (enrolling)
- Institut Claudius Regaud, IUCT Oncopole — Toulouse, France (enrolling)
- CHU Bretonneau — Tours, France (enrolling)
- Institut de Cancérologie de Lorraine — Vandœuvre-lès-Nancy, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.